GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $13,000 | 0.0% | 295 | +1.0% | 0.00% | 0.0% |
| Q1 2022 | $13,000 | 0.0% | 292 | +1.4% | 0.00% | 0.0% |
| Q4 2021 | $13,000 | +18.2% | 288 | +1.1% | 0.00% | 0.0% |
| Q3 2021 | $11,000 | 0.0% | 285 | +1.4% | 0.00% | -33.3% |
| Q2 2021 | $11,000 | +10.0% | 281 | +1.4% | 0.00% | 0.0% |
| Q1 2021 | $10,000 | -9.1% | 277 | -5.8% | 0.00% | -25.0% |
| Q4 2020 | $11,000 | 0.0% | 294 | +2.1% | 0.00% | -20.0% |
| Q3 2020 | $11,000 | +10.0% | 288 | +22.0% | 0.01% | 0.0% |
| Q2 2020 | $10,000 | +11.1% | 236 | +1.3% | 0.01% | -16.7% |
| Q1 2020 | $9,000 | -18.2% | 233 | +1.3% | 0.01% | 0.0% |
| Q4 2019 | $11,000 | +10.0% | 230 | +0.9% | 0.01% | -14.3% |
| Q3 2019 | $10,000 | +11.1% | 228 | +1.3% | 0.01% | 0.0% |
| Q2 2019 | $9,000 | 0.0% | 225 | +1.4% | 0.01% | 0.0% |
| Q1 2019 | $9,000 | +12.5% | 222 | +1.4% | 0.01% | 0.0% |
| Q4 2018 | $8,000 | – | 219 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |